Recover Investment Losses: Class Action Initiated Against Unicycive Therapeutics, Inc. (UNCY)
Levi & Korsinsky announced a securities class action filed against Unicycive Therapeutics covering investors who purchased UNCY securities between December 29, 2025 and June 29, 2026. The complaint alleges defendants failed to disclose they had not audited their third-party manufacturing vendor's cGMP compliance, creating risk that FDA approval of OLC would be delayed.
AI analysis
Red flags2 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.